Johanna W. Wilmink

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Eva Versteijne, Mustafa Suker, Karin Groothuis et al. · Journal of Clinical Oncology · 2020 · 1.1K citations · Full text

Medicine, Oncology, Surgery +15

Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma

Anouk E.J. Latenstein, Lydia G. van der Geest, Bert A. Bonsing et al. · European Journal of Cancer · 2019 · 178 citations · Full text

Medicine, Oncology, Surgery +15

Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial

Quisette P. Janssen, Jacob L. van Dam, B. Bonsing et al. · BMC Cancer · 2021 · 170 citations · Full text

Medicine, Oncology, Surgery +16

Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study

Marin Strijker, Ali Belkouz, Lydia G. van der Geest et al. · Acta Oncologica · 2019 · 120 citations · Full text

Medicine, Oncology, Surgery +17

The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis

Tara M. Mackay, F. Jasmijn Smits, Daphne Roos et al. · HPB · 2019 · 115 citations · Full text

Medicine, Oncology, Surgery +13